Mariner’s Abiomed Inc ABMD Stock Holding History

Mariner’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,767	Closed	-$1.66M	–	2877
2022 Q3	$1.66M	Buy	+6,767	New	+$1.83M	0.01%	847
2019 Q3	–	Sell	-1,394	Closed	-$363K	–	1088
2019 Q2	$363K	Buy	1,394 +150	+12%	+$39.8K	﹤0.01%	817
2019 Q1	$355K	Buy	+1,244	New	+$413K	0.01%	759

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's ABMD Position: Q4 2022 in Review

Mariner sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,767 shares — an estimated $1.66M sold.

Mariner first reported a position in ABMD in Q1 2019 and held it in 3 quarters. The position peaked at $1.66M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Mariner reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Mariner sold 6,767 Abiomed Inc shares in Q4 2022, an estimated $1.66M.
Mariner first reported a position in Abiomed Inc in Q1 2019 and held it in 3 quarters.
Mariner's Abiomed Inc position peaked at $1.66M in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mariner's 13F filing for Q4 2022, filed 14 Feb 2023.